Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Itraconazole | Correspondence

Is bronchial thermoplasty safe in allergic bronchopulmonary aspergillosis or severe asthma with fungal sensitization?

Authors: Valliappan Muthu, Ritesh Agarwal

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Excerpt

We read with interest the case presented by Sasada et al., describing the occurrence of aspergillosis in a patient who underwent bronchial thermoplasty (BT) [1]. The isolation of Aspergillus fumigatus, the presence of elevated serum total IgE, and possible eosinophilic inflammation (high FeNO) suggest allergic sensitization to A.fumigatus. However, the diagnosis remains unproven as specific IgE or skin test against A.fumigatus was not performed in the index case. The authors mention that there was a remarkable improvement after BT. With only two sessions of BT being completed, the observed improvement is likely the effect of itraconazole therapy. Itraconazole offers excellent results in patients with severe asthma with fungal sensitization (SAFS) and allergic bronchopulmonary aspergillosis (ABPA) [2, 3]. The absence of bronchiectasis on computed tomography does not rule out ABPA and therefore, immunological investigations are required [4]. The prevalence of Aspergillus sensitization is about 28% in asthmatics and maybe as high as 50% in those with severe asthma [5, 6]. …
Literature
1.
go back to reference Sasada S, Ohmura K, Oguri T, Fujimoto Y, Murata S, Tsuchiya Y, et al. A case report of aspergillosis accompanied by saccular bronchodilation after bronchial thermoplasty in a 19-year-old woman. Bmc Pulm Med. 2020;20(1):312.CrossRef Sasada S, Ohmura K, Oguri T, Fujimoto Y, Murata S, Tsuchiya Y, et al. A case report of aspergillosis accompanied by saccular bronchodilation after bronchial thermoplasty in a 19-year-old woman. Bmc Pulm Med. 2020;20(1):312.CrossRef
2.
go back to reference Denning DW, O’droscoll BR, Powell G, Chew F, Atherton GT, Vyas A, et al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: the fungal asthma sensitization trial (fast) study. Am J Respir Crit Care Med. 2009;179(1):11–8.CrossRef Denning DW, O’droscoll BR, Powell G, Chew F, Atherton GT, Vyas A, et al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: the fungal asthma sensitization trial (fast) study. Am J Respir Crit Care Med. 2009;179(1):11–8.CrossRef
3.
go back to reference Agarwal R, Dhooria S, Singh Sehgal I, Aggarwal AN, Garg M, Saikia B, et al. A randomized trial of itraconazole vs prednisolone in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Chest. 2018;153(3):656–64.CrossRef Agarwal R, Dhooria S, Singh Sehgal I, Aggarwal AN, Garg M, Saikia B, et al. A randomized trial of itraconazole vs prednisolone in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Chest. 2018;153(3):656–64.CrossRef
4.
go back to reference Agarwal R, Khan A, Garg M, Aggarwal AN, Gupta D. Chest radiographic and computed tomographic manifestations in allergic bronchopulmonary aspergillosis. World J Radiol. 2012;4(4):141–50.CrossRef Agarwal R, Khan A, Garg M, Aggarwal AN, Gupta D. Chest radiographic and computed tomographic manifestations in allergic bronchopulmonary aspergillosis. World J Radiol. 2012;4(4):141–50.CrossRef
5.
go back to reference Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2009;13(8):936–44.PubMed Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2009;13(8):936–44.PubMed
6.
go back to reference Agarwal R, Nath A, Aggarwal AN, Gupta D, Chakrabarti A. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in North India. Mycoses. 2010;53(2):138–43.CrossRef Agarwal R, Nath A, Aggarwal AN, Gupta D, Chakrabarti A. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in North India. Mycoses. 2010;53(2):138–43.CrossRef
7.
go back to reference Masaki K, Fukunaga K, Matsusaka M, Kabata H, Tanosaki T, Mochimaru T, et al. Characteristics of severe asthma with fungal sensitization. Ann Allergy Asthma Immunol. 2017;119(3):253–7.CrossRef Masaki K, Fukunaga K, Matsusaka M, Kabata H, Tanosaki T, Mochimaru T, et al. Characteristics of severe asthma with fungal sensitization. Ann Allergy Asthma Immunol. 2017;119(3):253–7.CrossRef
8.
go back to reference Majellano EC, Clark VI, Winter NA, Gibson PG, Mcdonald VM. Approaches to the assessment of severe asthma: barriers and strategies. J Asthma Allergy. 2019;12:235–51.CrossRef Majellano EC, Clark VI, Winter NA, Gibson PG, Mcdonald VM. Approaches to the assessment of severe asthma: barriers and strategies. J Asthma Allergy. 2019;12:235–51.CrossRef
9.
go back to reference Agarwal R, Gupta D. Severe asthma and fungi: current evidence. Med Mycol. 2011;49(Suppl 1):S150–7.CrossRef Agarwal R, Gupta D. Severe asthma and fungi: current evidence. Med Mycol. 2011;49(Suppl 1):S150–7.CrossRef
Metadata
Title
Is bronchial thermoplasty safe in allergic bronchopulmonary aspergillosis or severe asthma with fungal sensitization?
Authors
Valliappan Muthu
Ritesh Agarwal
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01535-1

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.